Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05315713
Title An Open-Label, Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab in Combination With Tiragolumab With or Without Atezolizumab in Participants With B-Cell Non-Hodgkin Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche

diffuse large B-cell lymphoma

follicular lymphoma


Mosunetuzumab + Tiragolumab + Tocilizumab

Atezolizumab + Mosunetuzumab + Tiragolumab + Tocilizumab

Age Groups: adult | senior
Covered Countries USA | DEU | CAN | BEL

No variant requirements are available.